Many of the editors at Technology Review are long-time science fiction fans–like many scientists, engineers, and entrepreneurs, our interest in science and technology was sparked by a heavy diet of science fiction in our youth. For us, science fiction is another way to approach the same fundamental question that drives us as technology journalists–once something new has been created, how will it change the world?
Of course, as journalists we are necessarily limited in our speculations and modest in our predictions, while science fiction writers are free to indulge their imaginations with little constraint. Still, from time to time, Technology Review has published science fiction in its pages, with stories from writers such as Greg Egan and David Marusek. We’ve done this because we think these writers had something insightful and provocative to say, something that spoke to the issues raised by technology that can’t be captured in an economist’s forecast or an expert’s quote.
With so many real-world events and trends to cover in our pages, however, these forays into fiction have been brief and sporadic. Consequently, we’ve decided to create a stand-alone special issue devoted to science fiction, a collection of all-new stories called TR:SF.
The stories within will be hard-science fiction tales set in the near future, loosely organized around the areas that Technology Review covers: computing, the Web, communications, energy, materials, and biomedicine. We are currently finalizing our slate of authors, which are a mixture of celebrated and emerging authors; stay tuned for more announcements. We’re still ironing out the distribution details too, but TR:SF will be on U.S. and Canadian newsstands and available for mail-order purchase internationally (we’re also looking at how we might distribute the issue electronically.)
We’re excited about this chance to publish, in the words of Jason Pontin, Technology Review’s editor-in-chief, some “good old, clanking, near-future SF” that will provoke thought, spark imaginations, and may even help inspire some real-world innovation.
Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.
A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.